Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF Priming with Trastuzumab in HER2+ Metastatic Breast Cancer
NCT00169104Phase 3Terminated
- Sponsor
- Dartmouth Health
- Start
- Jul 2002
- Primary completion
- Mar 2009
- Modality
- Cytokines & Interferons
01
Overview
A Phase 3 trial of filgrastim in breast cancer, sponsored by Dartmouth Health. Started Jul 2002; status: terminated.
02
Drugs
filgrastim
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00169104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00169104.